Live feed
Filing
SC 13D
SC 13D0001193125-21-318450·SV7 Impact Medicine Fund LP
Schedule 13D ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2021-10-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-318450
- Form type
- SC 13D
- Filer
- SV7 Impact Medicine Fund LP
- CIK
- CIK 1780602
- Filed
- Nov 03, 2021
- Reporting period
- Oct 26, 2021
- Description
- Schedule 13D beneficial ownership